Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (ViP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by University of Liverpool.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Dr Gary MIddleton, University of Liverpool Identifier:
First received: February 22, 2012
Last updated: May 16, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)